Related Experiment Video
Updated: Aug 3, 2026

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
Genetic pattern of prostate cancer progression
T Saric1, Z Brkanac, D A Troyer
1Department of Pathology, University of Texas Health Science Center at San Antonio, 78284-7750, USA.
Understanding genetic changes in prostate cancer (CaP) progression is crucial. This study identifies specific genetic alterations in metastatic CaP, offering potential biomarkers for tumor aggressiveness.
Area of Science:
- Oncology
- Genetics
- Cancer Research
Background:
- Genetic alterations in primary prostate cancer (CaP) are well-studied, but mechanisms driving progression to metastatic CaP remain unclear.
- This knowledge gap prevents distinguishing indolent from aggressive tumors.
- Autopsy-derived metastases are rarely analyzed, limiting understanding of CaP progression genetics.
Purpose of the Study:
- To investigate genetic differences between primary prostate cancer and its metastases.
- To identify genetic loci associated with prostate cancer progression and metastatic potential.
- To explore the utility of these genetic alterations as biomarkers for CaP aggressiveness.
Main Methods:
- Comparative analysis of loss of heterozygosity (LOH) profiles.
- Utilized 34 autopsy-derived metastatic CaP tissues.
- Compared LOH in metastases with 17 prostatectomy specimens (primary CaP and high-grade prostatic intraepithelial neoplasia - PIN).
- Analyzed 33 microsatellite markers on various chromosomes, including novel markers for metastatic CaP.
Main Results:
- LOH frequency increased progressively from PIN to primary CaP and metastases.
- Significant LOH in primary CaP occurred at loci on chromosomes 8p, 10q, 11p, 16q, 17p, 18q, and 21q.
- Metastatic CaP showed distinct LOH patterns, with some loci exhibiting up to a 7-fold increase compared to primary tumors.
- Identified novel LOH at D5S806, D6S262, D9S157, D13S133, and D13S227 in metastatic samples.
Conclusions:
- Stage-specific differences in LOH frequencies highlight key genetic loci involved in CaP progression.
- Identified genetic markers associated with metastatic potential.
- These findings could lead to clinically useful biomarkers for predicting CaP aggressiveness.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
07:34Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...